FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2137227164> ?p ?o ?g. }

• W2137227164 endingPage "E146" @default.
• W2137227164 startingPage "E139" @default.
• W2137227164 abstract "AMP-activated protein kinase (AMPK) and Rho kinase (ROK) are known to modulate the mevalonate pathway. Activation of AMPK suppresses 3-hydroxy-3-methylglutaryl (HMG)-coenzyme A (CoA) reductase. ROK acts downstream of HMG-CoA reductase, and its inhibition exerts antiatherosclerosis effects. However, whether or not these enzymes are involved in bone metabolism is unclear. The present study was undertaken to investigate the effects of an AMPK activator, 5-aminoimidazole-4-carboxamide1-β-d-ribonucleoside (AICAR), and a ROK inhibitor, fasudil hydrochrolide, on the mineralization of osteoblastic MC3T3-E1 cells. Real-time PCR and mineralization stainings revealed that both AICAR and fasudil significantly stimulated endothelial nitric oxide synthase (eNOS), bone morphogenetic protein-2 (BMP-2), and osteocalcin mRNA expression as well as mineralization in the cells. Supplementation of either mevalonate or geranyl-geranyl pyrophosphate, the downstream molecules of HMG-CoA reductase, or coincubation with either a nitric oxide synthase inhibitor, N G -nitro-l-arginine methyl ester, or a BMP-2 antagonist, noggin, significantly reversed these AICAR-induced reactions. Western blot analysis showed that AICAR activated protein kinase B and extracellular signal-regulated kinase (ERK). ERK inhibitor significantly reversed the AICAR-induced increase in eNOS and BMP-2 mRNA expression. Measurement of ROK activities by enzyme-linked immunosorbent assay revealed that both AICAR and fasudil significantly suppressed the phosphorylation of the myosin-binding subunit of myosin phosphate, a ROK substrate. These findings suggest that the AMPK activator and the ROK inhibitor are able to stimulate the mineralization of osteoblasts through modulating the mevalonate pathway. These agents could be candidate drugs that promote bone formation for the treatment of osteoporosis." @default.
• W2137227164 created "2016-06-24" @default.
• W2137227164 creator A5003005307 @default.
• W2137227164 creator A5020189160 @default.
• W2137227164 creator A5052396155 @default.
• W2137227164 creator A5075515448 @default.
• W2137227164 creator A5087014012 @default.
• W2137227164 date "2009-01-01" @default.
• W2137227164 modified "2023-10-02" @default.
• W2137227164 title "Activation of AMP kinase and inhibition of Rho kinase induce the mineralization of osteoblastic MC3T3-E1 cells through endothelial NOS and BMP-2 expression" @default.
• W2137227164 cites W1537398036 @default.
• W2137227164 cites W1537898230 @default.
• W2137227164 cites W1565979608 @default.
• W2137227164 cites W1704389558 @default.
• W2137227164 cites W1968223455 @default.
• W2137227164 cites W1970205234 @default.
• W2137227164 cites W1979615123 @default.
• W2137227164 cites W1979657364 @default.
• W2137227164 cites W1982085282 @default.
• W2137227164 cites W1983424760 @default.
• W2137227164 cites W1987247016 @default.
• W2137227164 cites W1987892305 @default.
• W2137227164 cites W1993919840 @default.
• W2137227164 cites W2000007398 @default.
• W2137227164 cites W2005132869 @default.
• W2137227164 cites W2011966598 @default.
• W2137227164 cites W2020364703 @default.
• W2137227164 cites W2026624731 @default.
• W2137227164 cites W2034698186 @default.
• W2137227164 cites W2038227076 @default.
• W2137227164 cites W2038727682 @default.
• W2137227164 cites W2042928998 @default.
• W2137227164 cites W2046354654 @default.
• W2137227164 cites W2051051060 @default.
• W2137227164 cites W2071124826 @default.
• W2137227164 cites W2072262871 @default.
• W2137227164 cites W2081546457 @default.
• W2137227164 cites W2084152511 @default.
• W2137227164 cites W2101305004 @default.
• W2137227164 cites W2101334610 @default.
• W2137227164 cites W2107277218 @default.
• W2137227164 cites W2108116605 @default.
• W2137227164 cites W2120684262 @default.
• W2137227164 cites W2128332272 @default.
• W2137227164 cites W2132822525 @default.
• W2137227164 cites W2149785020 @default.
• W2137227164 cites W2152791345 @default.
• W2137227164 cites W2155786049 @default.
• W2137227164 cites W2156013633 @default.
• W2137227164 cites W2164154096 @default.
• W2137227164 cites W4248270 @default.
• W2137227164 doi "https://doi.org/10.1152/ajpendo.90677.2008" @default.
• W2137227164 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19001547" @default.
• W2137227164 hasPublicationYear "2009" @default.
• W2137227164 type Work @default.
• W2137227164 sameAs 2137227164 @default.
• W2137227164 citedByCount "79" @default.
• W2137227164 countsByYear W21372271642012 @default.
• W2137227164 countsByYear W21372271642013 @default.
• W2137227164 countsByYear W21372271642014 @default.
• W2137227164 countsByYear W21372271642015 @default.
• W2137227164 countsByYear W21372271642016 @default.
• W2137227164 countsByYear W21372271642017 @default.
• W2137227164 countsByYear W21372271642018 @default.
• W2137227164 countsByYear W21372271642019 @default.
• W2137227164 countsByYear W21372271642020 @default.
• W2137227164 countsByYear W21372271642021 @default.
• W2137227164 countsByYear W21372271642022 @default.
• W2137227164 countsByYear W21372271642023 @default.
• W2137227164 crossrefType "journal-article" @default.
• W2137227164 hasAuthorship W2137227164A5003005307 @default.
• W2137227164 hasAuthorship W2137227164A5020189160 @default.
• W2137227164 hasAuthorship W2137227164A5052396155 @default.
• W2137227164 hasAuthorship W2137227164A5075515448 @default.
• W2137227164 hasAuthorship W2137227164A5087014012 @default.
• W2137227164 hasConcept C126322002 @default.
• W2137227164 hasConcept C134018914 @default.
• W2137227164 hasConcept C184235292 @default.
• W2137227164 hasConcept C185592680 @default.
• W2137227164 hasConcept C201800478 @default.
• W2137227164 hasConcept C2778609687 @default.
• W2137227164 hasConcept C2780124434 @default.
• W2137227164 hasConcept C55493867 @default.
• W2137227164 hasConcept C71924100 @default.
• W2137227164 hasConcept C86803240 @default.
• W2137227164 hasConcept C97029542 @default.
• W2137227164 hasConceptScore W2137227164C126322002 @default.
• W2137227164 hasConceptScore W2137227164C134018914 @default.
• W2137227164 hasConceptScore W2137227164C184235292 @default.
• W2137227164 hasConceptScore W2137227164C185592680 @default.
• W2137227164 hasConceptScore W2137227164C201800478 @default.
• W2137227164 hasConceptScore W2137227164C2778609687 @default.
• W2137227164 hasConceptScore W2137227164C2780124434 @default.
• W2137227164 hasConceptScore W2137227164C55493867 @default.
• W2137227164 hasConceptScore W2137227164C71924100 @default.
• W2137227164 hasConceptScore W2137227164C86803240 @default.
• W2137227164 hasConceptScore W2137227164C97029542 @default.
• W2137227164 hasIssue "1" @default.

• next